A2 Biotherapeutics

United States
Agoura Hills, California, United States, 91301

Company profile

A2 Biotherapeutics company profile

A2 Biotherapeutics focuses on innovative T cell therapies that precisely distinguish between solid tumors and normal cells. The proprietary Tmod™ platform integrates multiple signals to enhance treatment effectiveness while minimizing damage to healthy tissue.

Business identity

Contact email
[email protected]
Phone number
805-491-1988
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2018-01-01, Year

Headquarters

Postal code
91301
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
6
Total equity funding
$270.5M
Last funding
Grant / $300,000 / 2025-05-06
Last equity funding
Series C / $80M
Investors
9
Lead investors
1
Founders
1
Articles
53

Founders and investors

Founders

Alexander Kamb

Lead investors

ScaleReady

Investors

Casdin CapitalNextech InvestSamsara BioCapitalThe Column GroupVida Ventures